NCT02234336View on ClinicalTrials.gov

Assessment of Wall Thickness in Hypertrophic Cardiomyopathy

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 25, 2017

Study Completion Date

July 25, 2017

Conditions
Hypertrophic Cardiomyopathy
Interventions
PROCEDURE

Noncontrast echocardiography

PROCEDURE

Contrast Echocardiography

PROCEDURE

Cardiac magnetic resonance imaging

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Mayo Clinic

OTHER

NCT02234336 - Assessment of Wall Thickness in Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter